ChemBK
  • Home
  • Product Category
  • CHN
  1. Home
  2. CAS 1310460-85-5
  3. Supplier List
  4. MedChemExpress (MCE)
  5. Inhibitory Antibodies
  6. Futuximab

Request for quotation








Supplier Contact

Supplier NameMedChemExpress (MCE)
Contactsales
Tel609-228-6898
Mobile609-228-6898
QQ
Emailsales@medchemexpress.com; tech@medchemexpress.com
Websitehttps://www.medchemexpress.com/
Wechat
Product NameFutuximab
SynonymsFutuximab
CAS1310460-85-5
EINECS
Chemical Formula
Molecular Weight
inchi
Package1 mg;5 mg;10 mg
PriceEmail to quote
DescriptionsFutuximab

Futuximab

MedChemExpress (MCE)

HY-P99628

1310460-85-5

98.09%

Please store the product under the recommended conditions in the Certificate of Analysis.

Shipping with dry ice.

Futuximab is a chimeric monoclonal antibody targeting non-overlapping epitopes on EGFR. Futuximab has antineoplastic activity.

Futuximab (20 µg/mL

Descriptions

Futuximab

Futuximab

MedChemExpress (MCE)

HY-P99628

1310460-85-5

98.09%

Please store the product under the recommended conditions in the Certificate of Analysis.

Shipping with dry ice.

Futuximab is a chimeric monoclonal antibody targeting non-overlapping epitopes on EGFR. Futuximab has antineoplastic activity.

Futuximab (20 µg/mL
24-48 h) induces EGFR variant III (EGFRvIII) internalization and slightly reduces EGFRvIII levels in NR6M cells[1].

Futuximab (50 mg/kg
i.p.
twice weekly
for 5 weeks) shows anti-tumor activity in EGFRwt expressing xenograft model[1].

Chimeric

Human IgG1 kappa

Human IgG1 kappa, Isotype Control

| | | |

| | | | | |



[1]. Stephen T Keir, et al. Sym004-induced EGFR elimination is associated with profound anti-tumor activity in EGFRvIII patient-derived glioblastoma models. J Neurooncol. 2018 Jul
138(3):489-498. [Content Brief]

Supplier Websitehttps://www.medchemexpress.com/futuximab.html
Last Update2025-05-21 16:50:25
MedChemExpress (MCE) also provides

Depatuxizumab

Category: Inhibitory Antibodies
CAS: 1471999-69-5
Last Update: 2025-05-21 16:50:25

Raxibacumab

Category: Inhibitory Antibodies
CAS: 565451-13-0
Last Update: 2025-05-21 16:50:25

Crizanlizumab

Category: Inhibitory Antibodies
CAS: 1690318-25-2
Last Update: 2025-05-21 16:50:25

Sofituzumab vedotin

Category: Inhibitory Antibodies
CAS: 1418200-58-4
Last Update: 2025-05-21 16:50:25

Fazpilodemab

Category: Inhibitory Antibodies
CAS: 2517935-02-1
Last Update: 2025-05-21 16:50:25

Osemitamab

Category: Inhibitory Antibodies
CAS: 2460539-61-9
Last Update: 2025-05-21 16:50:25

Visugromab

Category: Inhibitory Antibodies
CAS: 2556646-63-8
Last Update: 2025-05-21 16:50:25

Vobramitamab

Category: Inhibitory Antibodies
CAS: 2490556-50-6
Last Update: 2025-05-21 16:50:25
  • Home
  • Product Category

© 2015 ChemBK.com All Rights Reserved | Build: 20150530002